Rocky Mountain Cancer Centers (RMCC),
Colorado's largest and most comprehensive provider of cancer care
throughout the state and an affiliate of The
US Oncology Network, has enhanced its community-based care network
in south Denver by adding two medical oncologists and their Greenwood
Village treatment center to the practice. Robin Kovachy, M.D., and
Lillian Klancar, M.D., joined Rocky Mountain Cancer Centers on January
1, 2015. Both physicians will continue to treat patients and provide
chemotherapy infusion services at their current facility in Greenwood
Village, which is now part of RMCC. The addition of this clinic expands
RMCC’s statewide network to 19 community-based locations.
“By adding Drs. Kovachy and Klancar and their treatment facility to our
practice, we gain the expertise of two highly skilled medical
oncologists, in addition to a new treatment location in Greenwood
Village,” said John Fleagle, president, Rocky Mountain Cancer Centers.
“This helps us meet the growing demand for our services in south Denver
by providing another convenient RMCC treatment center that can offer
timely access to quality care.”
Rocky Mountain Cancer Centers is a pioneer in delivering community-based
care, which provides a high-quality, cost-effective, more convenient
alternative to hospital care. Independent healthcare providers offer
advanced treatments that maximize convenience to patients at a lower
cost in facilities that are close to home.
Dr. Kovachy is no stranger to RMCC, having previously been part of its
Littleton practice for many years before leaving in 2008. Highly
respected and well known in the Denver medical community, Dr. Kovachy
has been in practice for more than 32 years and specializes in breast
cancer. She received her medical degree from Case Western Reserve
University and is board certified in Internal Medicine and Medical
Oncology.
“I am excited to rejoin Rocky Mountain Cancer Centers, and I look
forward to being part of a physician-led organization once again,” said
Dr. Kovachy. “We share a common vision of providing patients convenient
community access to advanced treatments that offer the best potential
for optimal outcomes, and I am anxious to once again be part of this
dedicated team of cancer specialists,” she noted.
Dr. Klancar is a graduate of the University of Colorado School of
Medicine where she completed her residency as well as part of her
Hematology-Oncology fellowship. She completed her fellowship at
University of Alabama in Birmingham. She specializes in general oncology
and hematology, lung, and breast and is board certified in Medical
Oncology.
“Rocky Mountain Cancer Centers’ commitment to delivering high-quality,
patient-centered care is well known in the cancer community, and I look
forward to collaborating with these like-minded, highly skilled cancer
specialists,” said Dr. Klancar. “The resources we gain by joining RMCC
and The US Oncology Network will be invaluable to us as we continue our
mission to provide each patient the best possible experience and
outcome.”
In addition to treating patients in the Greenwood Village office, Drs.
Kovachy and Klancar will provide valuable input into the development of
an innovative medical oncology sub-specialty treatment model RMCC’s
south Denver division is piloting for specific disease types. With the
vast amount of new cancer data released each year and the complexity of
cancer and its treatments, sub-specialty treatment models help ensure
patients receive the very latest cutting-edge treatment options that
offer optimal outcomes. Given the in-depth knowledge and expertise of
both physicians in their areas of interest, their contributions will be
significant in bringing the comprehensive model to fruition.
By joining RMCC, Drs. Kovachy and Klancar become part of The US Oncology
Network, providing them access to promising advanced treatments for
their patients, as well as many other services to enhance patient care,
treatment options and operational efficiency. They also gain access to
industry-leading evidence-based treatment pathways ―Value Pathways
powered by NCCN® ―to identify precise, clinically proven treatment
options that are the most effective for the majority of patients.
Additionally, they have new opportunities to collaborate with an
expanded physician community, including network-wide physician
committees and conferences, and The Oncology Portal, where approximately
1,000 physicians can share best practices and collaborate on complex
cases.
About Rocky Mountain Cancer Centers
Since 1992, Rocky Mountain Cancer Centers (RMCC) has been a leader in
cancer care. We began as a small group practice of six physicians with a
new approach to treating cancer—administering chemotherapy on an
outpatient basis—and have since developed into Colorado's largest and
most comprehensive provider of cancer care with 58 physicians treating
patients in 19 community-based locations across the state.
Through our culture of respect and collaboration we practice
evidence-based medicine and participate in clinical research to create
value and positive outcomes for our patients and families, referring
physicians and payers. To learn more, visit RockyMountainCancerCenters.com.
Rocky Mountain Cancer Centers is united in healing with The US Oncology
Network, one of the nation's largest networks of integrated
community-based oncology practices dedicated to advancing high-quality,
evidence-based patient care. As an affiliate of The US Oncology Network,
RMCC is united with 1,000 physicians nationwide. Rocky Mountain Cancer
Centers participates in clinical trials through US
Oncology Research, which has played a role in the development of 50
FDA approved cancer therapies―nearly one-third of all cancer therapies
used in treating cancer today. For more information, visit www.usoncology.com.
Copyright Business Wire 2015